SCHEMBL29020161

SCHEMBL29020161

O=C(O)c1cc(-c2ccc(C(F)(F)F)cc2)nc(Cl)n1.[KH]

nearest known ligand 0.61

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KMO O15229 5/20 0.61
CASP1 P29466 1/20 0.46
ADORA3 P0DMS8 1/20 0.45
P2RY14 Q15391 4/20 0.44
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
MCL1 Q07820 2/20 0.44
MARS1 P56192 1/20 0.44
TP53 P04637 1/20 0.44
POLB P06746 1/20 0.44
MAPT P10636 1/20 0.44
IGFBP3 P17936 1/20 0.42
TTR P02766 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3408828 0.99 KMO (0.62) KMOCASP1ADORA3P2RY14KDM4E
Potassium SCHEMBL29961608 0.97 KMO (0.61) KMOCASP1ADORA3P2RY14KDM4E
Dimethylformamide SCHEMBL27799820 0.89 KMO (0.52) KMOCASP1ADORA3P2RY14KDM4E
SCHEMBL29062398 0.85 KMO (0.68) KMOADORA3KDM4EALDH1A1MCL1
Potassium Ion SCHEMBL29020190 0.84 KMO (0.46) KMOCASP1ADORA3P2RY14ALDH1A1
SCHEMBL29020155 0.83 KMO (0.69) KMOKDM4EALDH1A1MCL1MAPT
SCHEMBL18002850 0.82 MAPT (0.48) KMOCASP1ADORA3KDM4EALDH1A1
SCHEMBL29020178 0.82 DHODH (0.57) KMOADORA3MCL1MARS1
SCHEMBL3404202 0.82 ADORA3 (0.45) KMOCASP1ADORA3KDM4EALDH1A1
SCHEMBL3560093 0.82 MCL1 (0.50) ADORA3P2RY14KDM4EALDH1A1MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115093400-B AhR inhibitor, application and preparation method thereof 北京华森英诺生物科技有限公司 2023-09-05 CN disclosed
CN-115093400-A AhR inhibitor and application and preparation method thereof 重庆华森制药股份有限公司 2022-09-23 CN disclosed